Dr. James Crowe Jr. receives SEC Faculty Achievement Award
Study shows new COVID target could improve vaccines
‘Friendly’ bacteria may impact COVID severity
Monoclonal antibody “cocktail” blocks COVID-19 variants: study
Study’s findings may help eventually close the door on COVID-19
Vanderbilt University Medical Center’s Crowe receives 2020 “Golden Goose” Award for COVID-19 research
It’s often hardest to collect data when you need it most, according to Elizabeth Zechmeister, Cornelius Vanderbilt Chair and professor of political science and director of the Latin American Public Opinion Project. When data is needed the most—when it is most informative—is often during times of civil unrest and national crises, such as a pandemic.
Vanderbilt University Medical Center has begun recruiting up to 250 participants for a phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.
Biophotonics researchers 3D print masks that accommodate filter changing
VUMC and AstraZeneca join forces to identify potential COVID-19 treatments